Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP4
|
ENSG00000105866.15 | SP4 |
PML
|
ENSG00000140464.20 | PML |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PML | hg38_v1_chr15_+_73994694_73994776 | 0.38 | 3.9e-02 | Click! |
SP4 | hg38_v1_chr7_+_21428023_21428112 | -0.09 | 6.5e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_708903 | 6.51 |
ENST00000338448.10
ENST00000264560.11 |
PALM
|
paralemmin |
chr5_-_180591488 | 5.52 |
ENST00000292641.4
|
SCGB3A1
|
secretoglobin family 3A member 1 |
chr1_+_205569005 | 5.20 |
ENST00000367147.9
ENST00000489709.5 |
MFSD4A
|
major facilitator superfamily domain containing 4A |
chr1_+_25616780 | 5.11 |
ENST00000374332.9
|
MAN1C1
|
mannosidase alpha class 1C member 1 |
chr7_-_158587710 | 4.84 |
ENST00000389416.8
|
PTPRN2
|
protein tyrosine phosphatase receptor type N2 |
chr3_+_13549117 | 4.78 |
ENST00000404922.8
|
FBLN2
|
fibulin 2 |
chr7_-_158587773 | 4.71 |
ENST00000389413.7
ENST00000409483.5 ENST00000389418.9 |
PTPRN2
|
protein tyrosine phosphatase receptor type N2 |
chr2_+_10721623 | 4.06 |
ENST00000272238.9
|
ATP6V1C2
|
ATPase H+ transporting V1 subunit C2 |
chr2_+_10721649 | 4.05 |
ENST00000381661.3
|
ATP6V1C2
|
ATPase H+ transporting V1 subunit C2 |
chr3_+_13549136 | 3.94 |
ENST00000295760.11
|
FBLN2
|
fibulin 2 |
chr10_+_45374204 | 3.69 |
ENST00000374391.7
|
ALOX5
|
arachidonate 5-lipoxygenase |
chr14_+_99793329 | 3.67 |
ENST00000334192.8
|
EML1
|
EMAP like 1 |
chr16_+_67431112 | 3.65 |
ENST00000326152.6
|
HSD11B2
|
hydroxysteroid 11-beta dehydrogenase 2 |
chr8_-_139704091 | 3.53 |
ENST00000648164.1
|
KCNK9
|
potassium two pore domain channel subfamily K member 9 |
chr21_+_42653734 | 3.51 |
ENST00000335512.8
ENST00000328862.10 ENST00000335440.10 ENST00000380328.6 ENST00000398225.7 ENST00000398227.7 ENST00000398229.7 ENST00000398232.7 ENST00000398234.7 ENST00000398236.7 ENST00000349112.7 ENST00000398224.3 |
PDE9A
|
phosphodiesterase 9A |
chr19_-_3029013 | 3.51 |
ENST00000590536.5
ENST00000587137.5 ENST00000455444.6 |
TLE2
|
TLE family member 2, transcriptional corepressor |
chr7_-_51316754 | 3.51 |
ENST00000632460.1
ENST00000441453.5 ENST00000648294.1 ENST00000265136.12 ENST00000395542.6 ENST00000395540.6 |
COBL
|
cordon-bleu WH2 repeat protein |
chr1_-_22143088 | 3.46 |
ENST00000290167.11
|
WNT4
|
Wnt family member 4 |
chr4_-_16083695 | 3.43 |
ENST00000510224.5
|
PROM1
|
prominin 1 |
chr10_+_45374167 | 3.40 |
ENST00000542434.5
|
ALOX5
|
arachidonate 5-lipoxygenase |
chr15_-_26773022 | 3.38 |
ENST00000311550.10
ENST00000622697.4 |
GABRB3
|
gamma-aminobutyric acid type A receptor subunit beta3 |
chr4_-_16083714 | 3.33 |
ENST00000508167.5
|
PROM1
|
prominin 1 |
chr10_-_13001705 | 3.32 |
ENST00000378825.5
|
CCDC3
|
coiled-coil domain containing 3 |
chrX_+_153072454 | 3.19 |
ENST00000421798.5
|
PNMA6A
|
PNMA family member 6A |
chr4_+_74933095 | 3.17 |
ENST00000513238.5
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
chr9_-_21994345 | 3.11 |
ENST00000579755.2
ENST00000530628.2 |
CDKN2A
|
cyclin dependent kinase inhibitor 2A |
chr4_-_148444674 | 3.06 |
ENST00000344721.8
|
NR3C2
|
nuclear receptor subfamily 3 group C member 2 |
chr16_-_56425424 | 2.99 |
ENST00000290649.10
|
AMFR
|
autocrine motility factor receptor |
chr8_-_141308280 | 2.99 |
ENST00000517878.6
|
SLC45A4
|
solute carrier family 45 member 4 |
chr14_-_64972143 | 2.97 |
ENST00000267512.9
|
RAB15
|
RAB15, member RAS oncogene family |
chr19_-_3029269 | 2.90 |
ENST00000262953.11
|
TLE2
|
TLE family member 2, transcriptional corepressor |
chr4_+_4387078 | 2.87 |
ENST00000504171.1
|
NSG1
|
neuronal vesicle trafficking associated 1 |
chr3_-_45226268 | 2.87 |
ENST00000503771.2
|
TMEM158
|
transmembrane protein 158 |
chr20_-_63831214 | 2.80 |
ENST00000302995.2
ENST00000245663.9 |
ZBTB46
|
zinc finger and BTB domain containing 46 |
chr9_-_33167296 | 2.77 |
ENST00000379731.5
ENST00000535206.5 |
B4GALT1
|
beta-1,4-galactosyltransferase 1 |
chr22_+_39456996 | 2.67 |
ENST00000341184.7
|
MGAT3
|
beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
chr8_-_139702998 | 2.66 |
ENST00000303015.2
|
KCNK9
|
potassium two pore domain channel subfamily K member 9 |
chr16_-_705726 | 2.64 |
ENST00000397621.6
ENST00000324361.9 |
FBXL16
|
F-box and leucine rich repeat protein 16 |
chr4_+_74933108 | 2.63 |
ENST00000307428.7
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
chr19_+_34481736 | 2.62 |
ENST00000590071.7
|
WTIP
|
WT1 interacting protein |
chr7_-_131556602 | 2.61 |
ENST00000322985.9
ENST00000378555.8 |
PODXL
|
podocalyxin like |
chr4_-_16084002 | 2.59 |
ENST00000447510.7
|
PROM1
|
prominin 1 |
chr4_+_7192519 | 2.56 |
ENST00000507866.6
|
SORCS2
|
sortilin related VPS10 domain containing receptor 2 |
chr10_-_98268186 | 2.54 |
ENST00000260702.4
|
LOXL4
|
lysyl oxidase like 4 |
chr12_+_49961864 | 2.54 |
ENST00000293599.7
|
AQP5
|
aquaporin 5 |
chr8_-_142777802 | 2.53 |
ENST00000621401.4
|
LYNX1
|
Ly6/neurotoxin 1 |
chr21_+_42653585 | 2.52 |
ENST00000291539.11
|
PDE9A
|
phosphodiesterase 9A |
chr14_-_64972233 | 2.50 |
ENST00000533601.7
|
RAB15
|
RAB15, member RAS oncogene family |
chr1_+_56645299 | 2.49 |
ENST00000371244.9
ENST00000610361.1 |
PRKAA2
|
protein kinase AMP-activated catalytic subunit alpha 2 |
chr19_+_8209320 | 2.49 |
ENST00000561053.5
ENST00000559450.5 ENST00000251363.10 ENST00000559336.5 |
CERS4
|
ceramide synthase 4 |
chr19_+_8209300 | 2.47 |
ENST00000558268.5
ENST00000558331.5 |
CERS4
|
ceramide synthase 4 |
chr2_+_8682046 | 2.38 |
ENST00000331129.3
ENST00000396290.2 |
ID2
|
inhibitor of DNA binding 2 |
chr8_-_142777174 | 2.36 |
ENST00000652477.1
ENST00000614491.1 ENST00000613110.4 |
LYNX1
|
Ly6/neurotoxin 1 |
chr19_+_50203607 | 2.35 |
ENST00000642316.2
ENST00000425460.6 ENST00000440075.6 ENST00000376970.6 ENST00000599920.5 |
MYH14
|
myosin heavy chain 14 |
chr17_+_82031643 | 2.25 |
ENST00000306897.9
|
RAC3
|
Rac family small GTPase 3 |
chr2_+_39665902 | 2.25 |
ENST00000281961.3
ENST00000618232.1 |
TMEM178A
|
transmembrane protein 178A |
chr1_-_51330527 | 2.24 |
ENST00000439482.6
|
TTC39A
|
tetratricopeptide repeat domain 39A |
chr13_-_36920227 | 2.22 |
ENST00000379826.5
ENST00000350148.10 |
SMAD9
|
SMAD family member 9 |
chr14_+_99793375 | 2.21 |
ENST00000262233.11
ENST00000556714.5 |
EML1
|
EMAP like 1 |
chr19_-_461007 | 2.20 |
ENST00000264554.11
|
SHC2
|
SHC adaptor protein 2 |
chr10_-_15371225 | 2.20 |
ENST00000378116.9
|
FAM171A1
|
family with sequence similarity 171 member A1 |
chr10_+_12349533 | 2.19 |
ENST00000619168.5
|
CAMK1D
|
calcium/calmodulin dependent protein kinase ID |
chr15_-_93089192 | 2.19 |
ENST00000329082.11
|
RGMA
|
repulsive guidance molecule BMP co-receptor a |
chr3_+_41199462 | 2.15 |
ENST00000647264.1
ENST00000645900.1 ENST00000646174.1 ENST00000643992.1 ENST00000647390.1 ENST00000642886.1 |
CTNNB1
|
catenin beta 1 |
chr12_+_101697621 | 2.13 |
ENST00000229266.8
ENST00000549872.5 |
CHPT1
|
choline phosphotransferase 1 |
chr22_-_17121311 | 2.10 |
ENST00000331437.4
ENST00000399875.1 |
TMEM121B
|
transmembrane protein 121B |
chr15_-_78131225 | 2.07 |
ENST00000561190.5
ENST00000559645.1 ENST00000560618.5 ENST00000559054.1 |
CIB2
|
calcium and integrin binding family member 2 |
chr21_+_6111123 | 2.07 |
ENST00000613488.3
|
SIK1B
|
salt inducible kinase 1B (putative) |
chr4_+_41360759 | 2.07 |
ENST00000508501.5
ENST00000512946.5 ENST00000313860.11 ENST00000512632.5 ENST00000512820.5 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr7_+_101815983 | 2.05 |
ENST00000292538.9
ENST00000622516.6 ENST00000393824.7 ENST00000547394.6 ENST00000360264.7 ENST00000425244.6 |
CUX1
|
cut like homeobox 1 |
chr19_-_18606779 | 2.04 |
ENST00000684169.1
ENST00000392386.8 |
CRLF1
|
cytokine receptor like factor 1 |
chr16_+_2026834 | 2.03 |
ENST00000424542.7
ENST00000432365.6 |
SLC9A3R2
|
SLC9A3 regulator 2 |
chr16_-_52547113 | 2.03 |
ENST00000219746.14
|
TOX3
|
TOX high mobility group box family member 3 |
chr10_+_45374235 | 2.01 |
ENST00000612635.4
|
ALOX5
|
arachidonate 5-lipoxygenase |
chr19_-_7294406 | 1.96 |
ENST00000302850.10
|
INSR
|
insulin receptor |
chr20_+_59577463 | 1.96 |
ENST00000359926.7
|
PHACTR3
|
phosphatase and actin regulator 3 |
chr4_-_1683991 | 1.96 |
ENST00000472884.6
ENST00000489363.5 ENST00000308132.10 |
FAM53A
|
family with sequence similarity 53 member A |
chr16_+_69566314 | 1.92 |
ENST00000565301.2
|
NFAT5
|
nuclear factor of activated T cells 5 |
chr11_+_369461 | 1.91 |
ENST00000329962.11
|
B4GALNT4
|
beta-1,4-N-acetyl-galactosaminyltransferase 4 |
chr9_-_21974821 | 1.90 |
ENST00000304494.10
ENST00000579122.1 ENST00000498124.1 |
CDKN2A
|
cyclin dependent kinase inhibitor 2A |
chr16_-_66925526 | 1.89 |
ENST00000299759.11
ENST00000420652.5 |
RRAD
|
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
chr13_-_109786567 | 1.89 |
ENST00000375856.5
|
IRS2
|
insulin receptor substrate 2 |
chr22_-_19150292 | 1.88 |
ENST00000086933.3
|
GSC2
|
goosecoid homeobox 2 |
chr4_+_4387039 | 1.88 |
ENST00000621129.4
|
NSG1
|
neuronal vesicle trafficking associated 1 |
chr17_-_1628808 | 1.86 |
ENST00000301335.10
|
SLC43A2
|
solute carrier family 43 member 2 |
chr7_-_139777986 | 1.86 |
ENST00000406875.8
|
HIPK2
|
homeodomain interacting protein kinase 2 |
chr9_+_17579059 | 1.84 |
ENST00000380607.5
|
SH3GL2
|
SH3 domain containing GRB2 like 2, endophilin A1 |
chr21_-_43427131 | 1.83 |
ENST00000270162.8
|
SIK1
|
salt inducible kinase 1 |
chr12_-_62935117 | 1.83 |
ENST00000228705.7
|
PPM1H
|
protein phosphatase, Mg2+/Mn2+ dependent 1H |
chr19_-_17026795 | 1.83 |
ENST00000443236.7
|
CPAMD8
|
C3 and PZP like alpha-2-macroglobulin domain containing 8 |
chr11_+_13668702 | 1.81 |
ENST00000532701.1
|
FAR1
|
fatty acyl-CoA reductase 1 |
chr9_-_137302264 | 1.81 |
ENST00000356628.4
|
NRARP
|
NOTCH regulated ankyrin repeat protein |
chr22_-_18936142 | 1.80 |
ENST00000438924.5
ENST00000457083.1 ENST00000357068.11 ENST00000420436.5 ENST00000334029.6 ENST00000610940.4 |
PRODH
|
proline dehydrogenase 1 |
chr1_-_231040218 | 1.80 |
ENST00000366654.5
|
FAM89A
|
family with sequence similarity 89 member A |
chr11_-_93543382 | 1.80 |
ENST00000298966.7
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
chr11_+_2444986 | 1.80 |
ENST00000155840.12
|
KCNQ1
|
potassium voltage-gated channel subfamily Q member 1 |
chr13_-_113864062 | 1.79 |
ENST00000327773.7
|
GAS6
|
growth arrest specific 6 |
chr17_+_70169516 | 1.77 |
ENST00000243457.4
|
KCNJ2
|
potassium inwardly rectifying channel subfamily J member 2 |
chr2_+_119431846 | 1.75 |
ENST00000306406.5
|
TMEM37
|
transmembrane protein 37 |
chr2_+_64453969 | 1.75 |
ENST00000464281.5
|
LGALSL
|
galectin like |
chr1_+_236142526 | 1.74 |
ENST00000366592.8
|
GPR137B
|
G protein-coupled receptor 137B |
chr6_-_89412069 | 1.73 |
ENST00000359203.3
|
RRAGD
|
Ras related GTP binding D |
chr7_-_152435786 | 1.73 |
ENST00000682283.1
ENST00000679882.1 ENST00000452749.2 ENST00000683616.1 ENST00000262189.11 ENST00000683490.1 ENST00000681082.1 ENST00000684550.1 |
KMT2C
|
lysine methyltransferase 2C |
chr5_-_16616972 | 1.73 |
ENST00000682564.1
ENST00000306320.10 ENST00000682229.1 |
RETREG1
|
reticulophagy regulator 1 |
chr3_+_23945271 | 1.72 |
ENST00000312521.9
|
NR1D2
|
nuclear receptor subfamily 1 group D member 2 |
chr14_-_100159595 | 1.72 |
ENST00000553834.1
ENST00000305631.7 |
DEGS2
|
delta 4-desaturase, sphingolipid 2 |
chr16_-_66696680 | 1.71 |
ENST00000330687.8
ENST00000563952.1 ENST00000394106.7 |
CMTM4
|
CKLF like MARVEL transmembrane domain containing 4 |
chr16_+_69566041 | 1.69 |
ENST00000567239.5
|
NFAT5
|
nuclear factor of activated T cells 5 |
chr12_-_29783798 | 1.69 |
ENST00000552618.5
ENST00000551659.5 ENST00000539277.6 |
TMTC1
|
transmembrane O-mannosyltransferase targeting cadherins 1 |
chr6_+_36196710 | 1.69 |
ENST00000357641.10
|
BRPF3
|
bromodomain and PHD finger containing 3 |
chrX_-_2500555 | 1.68 |
ENST00000381218.8
|
ZBED1
|
zinc finger BED-type containing 1 |
chr15_-_26773737 | 1.68 |
ENST00000299267.8
|
GABRB3
|
gamma-aminobutyric acid type A receptor subunit beta3 |
chr7_+_116672357 | 1.67 |
ENST00000456159.1
|
MET
|
MET proto-oncogene, receptor tyrosine kinase |
chr1_-_160098675 | 1.66 |
ENST00000368086.5
ENST00000614243.4 ENST00000448417.1 |
IGSF8
|
immunoglobulin superfamily member 8 |
chr11_+_86800507 | 1.66 |
ENST00000533902.2
|
PRSS23
|
serine protease 23 |
chr5_+_157266079 | 1.66 |
ENST00000616178.4
ENST00000522463.5 ENST00000435847.6 ENST00000620254.5 ENST00000521420.5 ENST00000617629.4 |
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr1_-_160098593 | 1.64 |
ENST00000314485.12
|
IGSF8
|
immunoglobulin superfamily member 8 |
chr17_-_57955242 | 1.63 |
ENST00000577840.5
|
CUEDC1
|
CUE domain containing 1 |
chr19_-_4065732 | 1.62 |
ENST00000601588.1
|
ZBTB7A
|
zinc finger and BTB domain containing 7A |
chr2_+_86913812 | 1.61 |
ENST00000398193.8
|
RGPD1
|
RANBP2 like and GRIP domain containing 1 |
chr7_-_117873420 | 1.61 |
ENST00000160373.8
|
CTTNBP2
|
cortactin binding protein 2 |
chr19_-_5567984 | 1.61 |
ENST00000448587.5
|
TINCR
|
TINCR ubiquitin domain containing |
chr3_+_196744 | 1.60 |
ENST00000256509.7
ENST00000397491.6 |
CHL1
|
cell adhesion molecule L1 like |
chr19_+_1491140 | 1.59 |
ENST00000233596.8
ENST00000395479.10 |
REEP6
|
receptor accessory protein 6 |
chr19_-_7926106 | 1.59 |
ENST00000318978.6
|
CTXN1
|
cortexin 1 |
chr19_-_14206168 | 1.59 |
ENST00000361434.7
ENST00000340736.10 |
ADGRL1
|
adhesion G protein-coupled receptor L1 |
chr2_-_189580773 | 1.59 |
ENST00000261024.7
|
SLC40A1
|
solute carrier family 40 member 1 |
chr11_+_289155 | 1.58 |
ENST00000409655.5
|
PGGHG
|
protein-glucosylgalactosylhydroxylysine glucosidase |
chr17_+_82032061 | 1.58 |
ENST00000580965.5
|
RAC3
|
Rac family small GTPase 3 |
chrX_+_69504320 | 1.57 |
ENST00000252338.5
|
FAM155B
|
family with sequence similarity 155 member B |
chr6_-_11044275 | 1.57 |
ENST00000354666.4
|
ELOVL2
|
ELOVL fatty acid elongase 2 |
chr4_+_159103010 | 1.56 |
ENST00000644474.1
|
RAPGEF2
|
Rap guanine nucleotide exchange factor 2 |
chr5_+_10564064 | 1.55 |
ENST00000296657.7
|
ANKRD33B
|
ankyrin repeat domain 33B |
chr12_+_128267162 | 1.55 |
ENST00000435159.3
|
TMEM132C
|
transmembrane protein 132C |
chr21_+_41316747 | 1.54 |
ENST00000357985.7
ENST00000398647.7 ENST00000398652.7 |
FAM3B
|
FAM3 metabolism regulating signaling molecule B |
chr7_-_139777774 | 1.53 |
ENST00000428878.6
|
HIPK2
|
homeodomain interacting protein kinase 2 |
chr8_+_25184758 | 1.53 |
ENST00000481100.5
|
DOCK5
|
dedicator of cytokinesis 5 |
chr17_-_78925376 | 1.52 |
ENST00000262768.11
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr7_-_130668705 | 1.52 |
ENST00000330992.8
ENST00000425248.5 |
COPG2
|
COPI coat complex subunit gamma 2 |
chr20_-_33443651 | 1.52 |
ENST00000217381.3
|
SNTA1
|
syntrophin alpha 1 |
chr17_+_78232006 | 1.52 |
ENST00000550981.7
ENST00000591033.2 |
TMEM235
|
transmembrane protein 235 |
chr9_+_129665603 | 1.51 |
ENST00000372469.6
|
PRRX2
|
paired related homeobox 2 |
chr13_+_34942263 | 1.49 |
ENST00000379939.7
ENST00000400445.7 |
NBEA
|
neurobeachin |
chrX_-_3713593 | 1.49 |
ENST00000262848.6
|
PRKX
|
protein kinase X-linked |
chr15_-_93073111 | 1.49 |
ENST00000557420.1
ENST00000542321.6 |
RGMA
|
repulsive guidance molecule BMP co-receptor a |
chr4_-_148442508 | 1.49 |
ENST00000625323.2
|
NR3C2
|
nuclear receptor subfamily 3 group C member 2 |
chr6_-_29628038 | 1.47 |
ENST00000355973.7
ENST00000377012.8 |
GABBR1
|
gamma-aminobutyric acid type B receptor subunit 1 |
chr1_-_201115372 | 1.47 |
ENST00000458416.2
|
ASCL5
|
achaete-scute family bHLH transcription factor 5 |
chr20_-_63499074 | 1.47 |
ENST00000217182.6
ENST00000642899.1 |
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr4_+_1793776 | 1.47 |
ENST00000352904.6
|
FGFR3
|
fibroblast growth factor receptor 3 |
chrX_+_16946650 | 1.46 |
ENST00000357277.8
|
REPS2
|
RALBP1 associated Eps domain containing 2 |
chr8_-_100309904 | 1.46 |
ENST00000523481.5
|
RNF19A
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
chr11_+_62337424 | 1.46 |
ENST00000415229.6
ENST00000301776.9 ENST00000628829.2 ENST00000534571.5 ENST00000526096.2 |
ASRGL1
|
asparaginase and isoaspartyl peptidase 1 |
chr15_-_65422894 | 1.46 |
ENST00000352385.3
|
IGDCC4
|
immunoglobulin superfamily DCC subclass member 4 |
chr5_-_16179783 | 1.46 |
ENST00000332432.9
|
MARCHF11
|
membrane associated ring-CH-type finger 11 |
chr10_-_13099652 | 1.45 |
ENST00000378839.1
|
CCDC3
|
coiled-coil domain containing 3 |
chr1_+_212608628 | 1.44 |
ENST00000613954.4
ENST00000341491.9 ENST00000366985.5 |
ATF3
|
activating transcription factor 3 |
chr14_-_105168753 | 1.43 |
ENST00000331782.8
ENST00000347004.2 |
JAG2
|
jagged canonical Notch ligand 2 |
chrX_+_16946862 | 1.43 |
ENST00000303843.7
|
REPS2
|
RALBP1 associated Eps domain containing 2 |
chr22_-_43187078 | 1.43 |
ENST00000216129.7
|
TTLL12
|
tubulin tyrosine ligase like 12 |
chr5_-_123036664 | 1.43 |
ENST00000306442.5
|
PPIC
|
peptidylprolyl isomerase C |
chr8_-_144060681 | 1.42 |
ENST00000618853.5
|
OPLAH
|
5-oxoprolinase, ATP-hydrolysing |
chr19_-_2721332 | 1.42 |
ENST00000588128.1
ENST00000323469.5 |
DIRAS1
|
DIRAS family GTPase 1 |
chr15_+_73052449 | 1.42 |
ENST00000261908.11
|
NEO1
|
neogenin 1 |
chr11_-_61581104 | 1.41 |
ENST00000263846.8
|
SYT7
|
synaptotagmin 7 |
chr1_+_150549384 | 1.41 |
ENST00000369041.9
ENST00000271643.9 |
ADAMTSL4
|
ADAMTS like 4 |
chr1_+_64470120 | 1.40 |
ENST00000651257.2
|
CACHD1
|
cache domain containing 1 |
chr2_-_219387881 | 1.39 |
ENST00000322176.11
ENST00000273075.9 |
DNPEP
|
aspartyl aminopeptidase |
chr2_-_6865901 | 1.39 |
ENST00000256722.10
|
CMPK2
|
cytidine/uridine monophosphate kinase 2 |
chr3_-_158732442 | 1.39 |
ENST00000479756.1
ENST00000237696.10 |
RARRES1
|
retinoic acid receptor responder 1 |
chr11_+_289108 | 1.38 |
ENST00000409548.7
|
PGGHG
|
protein-glucosylgalactosylhydroxylysine glucosidase |
chr1_+_229626170 | 1.38 |
ENST00000258243.7
|
URB2
|
URB2 ribosome biogenesis homolog |
chr15_+_28885955 | 1.38 |
ENST00000558402.5
ENST00000683413.1 ENST00000558330.5 |
APBA2
|
amyloid beta precursor protein binding family A member 2 |
chr8_+_144517977 | 1.38 |
ENST00000527730.1
ENST00000292524.6 ENST00000529022.5 |
LRRC14
|
leucine rich repeat containing 14 |
chr3_+_41200080 | 1.38 |
ENST00000644524.1
|
CTNNB1
|
catenin beta 1 |
chr14_+_103123452 | 1.38 |
ENST00000558056.1
ENST00000560869.6 |
TNFAIP2
|
TNF alpha induced protein 2 |
chr4_+_4386498 | 1.38 |
ENST00000433139.6
|
NSG1
|
neuronal vesicle trafficking associated 1 |
chr18_+_58044217 | 1.36 |
ENST00000400345.8
|
NEDD4L
|
NEDD4 like E3 ubiquitin protein ligase |
chr2_+_11155372 | 1.35 |
ENST00000441908.6
ENST00000295083.8 |
SLC66A3
|
solute carrier family 66 member 3 |
chr19_-_1513189 | 1.35 |
ENST00000395467.6
|
ADAMTSL5
|
ADAMTS like 5 |
chr19_+_51311638 | 1.35 |
ENST00000270642.9
|
IGLON5
|
IgLON family member 5 |
chr16_-_788329 | 1.35 |
ENST00000563560.1
ENST00000569601.5 ENST00000565809.5 ENST00000007264.7 ENST00000565377.1 ENST00000567114.5 |
RPUSD1
|
RNA pseudouridine synthase domain containing 1 |
chr12_-_104958268 | 1.34 |
ENST00000432951.1
ENST00000258538.8 ENST00000415674.1 ENST00000424946.1 ENST00000433540.5 |
SLC41A2
|
solute carrier family 41 member 2 |
chr13_-_95301319 | 1.34 |
ENST00000646439.1
ENST00000645532.1 |
ABCC4
|
ATP binding cassette subfamily C member 4 |
chr17_+_82032182 | 1.34 |
ENST00000584341.1
|
RAC3
|
Rac family small GTPase 3 |
chr9_+_127397153 | 1.33 |
ENST00000451404.5
ENST00000373371.8 |
SLC2A8
|
solute carrier family 2 member 8 |
chr2_+_6865557 | 1.33 |
ENST00000680607.1
ENST00000680320.1 ENST00000442639.6 |
RSAD2
|
radical S-adenosyl methionine domain containing 2 |
chr4_-_88284747 | 1.33 |
ENST00000514204.1
|
PPM1K
|
protein phosphatase, Mg2+/Mn2+ dependent 1K |
chr22_-_31107517 | 1.32 |
ENST00000400299.6
ENST00000611680.1 |
SELENOM
|
selenoprotein M |
chr14_-_100306430 | 1.32 |
ENST00000392908.7
ENST00000359232.8 |
SLC25A29
|
solute carrier family 25 member 29 |
chr17_+_59331633 | 1.32 |
ENST00000312655.9
|
YPEL2
|
yippee like 2 |
chr2_+_10302867 | 1.31 |
ENST00000423674.5
ENST00000307845.8 |
HPCAL1
|
hippocalcin like 1 |
chr9_+_127397184 | 1.31 |
ENST00000419917.5
ENST00000373352.5 ENST00000373360.7 |
SLC2A8
|
solute carrier family 2 member 8 |
chr9_-_83063159 | 1.30 |
ENST00000340717.4
|
RASEF
|
RAS and EF-hand domain containing |
chr7_-_102616692 | 1.30 |
ENST00000521076.5
ENST00000462172.5 ENST00000522801.5 ENST00000262940.12 ENST00000449970.6 |
RASA4
|
RAS p21 protein activator 4 |
chr13_-_26052009 | 1.30 |
ENST00000319420.4
|
SHISA2
|
shisa family member 2 |
chr9_+_97853217 | 1.29 |
ENST00000375123.5
|
FOXE1
|
forkhead box E1 |
chr1_-_227318453 | 1.29 |
ENST00000366769.7
ENST00000366766.7 |
CDC42BPA
|
CDC42 binding protein kinase alpha |
chr13_-_36131286 | 1.29 |
ENST00000255448.8
ENST00000379892.4 |
DCLK1
|
doublecortin like kinase 1 |
chr11_-_33869816 | 1.29 |
ENST00000395833.7
|
LMO2
|
LIM domain only 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 9.1 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
1.6 | 6.2 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
1.4 | 4.1 | GO:0072034 | renal vesicle induction(GO:0072034) |
1.3 | 9.1 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
1.0 | 6.3 | GO:1904499 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
0.9 | 2.8 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.9 | 6.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.9 | 2.6 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.9 | 0.9 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.8 | 2.4 | GO:0071931 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) |
0.8 | 0.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.8 | 3.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.8 | 3.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 2.8 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.7 | 3.4 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 7.4 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.7 | 2.0 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.7 | 2.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.7 | 5.9 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.6 | 2.6 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.6 | 2.5 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.6 | 1.9 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.6 | 1.9 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
0.6 | 1.8 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.6 | 0.6 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.6 | 1.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.6 | 2.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.6 | 1.7 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.6 | 2.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.6 | 1.7 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
0.6 | 1.7 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.6 | 2.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 3.3 | GO:0035602 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
0.5 | 1.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.5 | 1.6 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.5 | 2.2 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.5 | 2.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.5 | 2.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 1.5 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.5 | 2.0 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
0.5 | 2.5 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.5 | 2.4 | GO:0003069 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.5 | 1.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.5 | 1.4 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.5 | 1.9 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.5 | 1.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.5 | 3.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.5 | 1.4 | GO:0010932 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
0.5 | 1.4 | GO:0070662 | mast cell proliferation(GO:0070662) |
0.5 | 1.4 | GO:0034148 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
0.5 | 0.9 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.4 | 1.8 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.4 | 1.3 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
0.4 | 1.3 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.4 | 3.9 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 3.0 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.4 | 3.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.4 | 3.4 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.4 | 1.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.4 | 2.1 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.4 | 0.4 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.4 | 0.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 3.3 | GO:0035934 | corticosterone secretion(GO:0035934) |
0.4 | 1.2 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.4 | 1.6 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
0.4 | 2.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.4 | 8.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.4 | 1.2 | GO:0021503 | neural fold bending(GO:0021503) |
0.4 | 1.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.4 | 1.2 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.4 | 1.2 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.4 | 2.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 1.5 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 1.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.4 | 1.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 2.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.4 | 1.9 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.4 | 0.4 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.4 | 1.5 | GO:0018032 | protein amidation(GO:0018032) |
0.4 | 1.1 | GO:0060957 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) positive regulation of determination of dorsal identity(GO:2000017) |
0.4 | 2.2 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.4 | 1.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.4 | 1.1 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.4 | 2.5 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 1.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 3.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.3 | 1.0 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.3 | 1.4 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.3 | 1.4 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.3 | 0.3 | GO:0072054 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
0.3 | 1.4 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.3 | 1.0 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.3 | 1.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 2.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.3 | 1.0 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.3 | 1.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.3 | 1.6 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.3 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 1.0 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.3 | 1.6 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.3 | 11.8 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
0.3 | 0.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.3 | 1.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.3 | 0.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.3 | 1.6 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 2.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.3 | 0.9 | GO:1903762 | positive regulation of actin filament-based movement(GO:1903116) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.3 | 1.5 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) |
0.3 | 1.2 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.3 | 2.8 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 | 1.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 0.9 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
0.3 | 1.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.3 | 0.3 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.3 | 2.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 0.9 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.3 | 0.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 1.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 1.5 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.3 | 0.6 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
0.3 | 0.9 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.3 | 0.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 3.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 0.3 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.3 | 1.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.3 | 0.9 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.3 | 1.1 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.3 | 0.8 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.3 | 0.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 0.8 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.3 | 0.8 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.3 | 1.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 1.1 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.3 | 0.8 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.3 | 1.9 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 1.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.3 | 2.1 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 0.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.3 | 1.1 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.3 | 0.5 | GO:1900168 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
0.3 | 0.5 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.3 | 0.3 | GO:1990834 | response to odorant(GO:1990834) |
0.3 | 9.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 2.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 0.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.3 | 0.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 9.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.3 | 2.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 1.0 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.2 | 1.0 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.2 | 2.0 | GO:0061709 | reticulophagy(GO:0061709) |
0.2 | 0.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.2 | 1.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.2 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 3.4 | GO:0015866 | ADP transport(GO:0015866) |
0.2 | 1.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 1.9 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.2 | 2.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.7 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.2 | 2.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.2 | 1.0 | GO:1904179 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
0.2 | 1.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 1.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 0.5 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 | 0.5 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.2 | 0.9 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.2 | 1.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.2 | 0.2 | GO:0090212 | negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.2 | 0.7 | GO:0043324 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.2 | 1.1 | GO:2000690 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.2 | 0.9 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.2 | 0.7 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.2 | 0.2 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.2 | 1.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.2 | GO:2000506 | negative regulation of energy homeostasis(GO:2000506) |
0.2 | 0.7 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.2 | 3.4 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.2 | 0.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 0.7 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.2 | 0.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.2 | 0.9 | GO:0072302 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
0.2 | 0.9 | GO:0043335 | protein unfolding(GO:0043335) |
0.2 | 1.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 3.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 4.6 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.2 | 1.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.7 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 1.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 0.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.2 | 5.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 2.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.9 | GO:0009405 | pathogenesis(GO:0009405) |
0.2 | 0.6 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.2 | 0.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.2 | 0.6 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.2 | 0.6 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.2 | 0.8 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 1.3 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.2 | 0.8 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.2 | 0.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 3.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 1.9 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.2 | 1.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 2.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 2.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 1.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 1.4 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.2 | 0.2 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.2 | 2.7 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 0.6 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.2 | 1.0 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.2 | 0.8 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
0.2 | 0.6 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 1.4 | GO:0050893 | sensory processing(GO:0050893) |
0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 0.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.2 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
0.2 | 1.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 0.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.8 | GO:0061441 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) renal artery morphogenesis(GO:0061441) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.2 | 0.6 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 2.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 1.2 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
0.2 | 0.8 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 1.0 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.2 | 4.3 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 3.5 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.2 | 1.2 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.6 | GO:0051463 | negative regulation of cortisol secretion(GO:0051463) |
0.2 | 0.6 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.2 | 0.2 | GO:0034776 | response to histamine(GO:0034776) |
0.2 | 4.7 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.2 | 1.3 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.2 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 1.7 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.8 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.2 | 0.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.2 | 0.6 | GO:0071529 | cementum mineralization(GO:0071529) |
0.2 | 1.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.9 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 1.5 | GO:0072177 | mesonephric duct development(GO:0072177) |
0.2 | 1.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 0.6 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.2 | 1.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 3.1 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 0.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 1.5 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.2 | 2.0 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 1.5 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 1.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 3.8 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.2 | 2.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.2 | 1.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.7 | GO:2000077 | negative regulation of type B pancreatic cell development(GO:2000077) |
0.2 | 0.7 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.2 | 1.1 | GO:0051167 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.7 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.2 | 0.9 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 0.5 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.2 | 0.2 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.2 | 1.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 2.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.2 | 0.5 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 0.7 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.2 | 0.5 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.2 | 2.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 1.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.2 | 2.6 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 2.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 5.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.2 | 0.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 1.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 6.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 0.5 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
0.2 | 0.8 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 2.0 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.2 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 0.8 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.2 | 0.7 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.2 | 0.2 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.2 | 0.5 | GO:0060309 | elastin catabolic process(GO:0060309) |
0.2 | 2.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.8 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.2 | 0.3 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.2 | 0.5 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
0.2 | 2.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.2 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.2 | 5.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.2 | 4.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 3.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.6 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.2 | 0.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 2.3 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.2 | 0.5 | GO:1904907 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.2 | 0.3 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 1.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 0.5 | GO:2000697 | kidney mesenchymal cell proliferation(GO:0072135) metanephric mesenchymal cell proliferation involved in metanephros development(GO:0072136) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
0.2 | 1.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 1.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 0.6 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.2 | 1.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 1.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.2 | 0.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.6 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.2 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 0.5 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.2 | 0.5 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.2 | 0.8 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
0.2 | 0.2 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 0.3 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.2 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 1.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.9 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 0.8 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 2.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.6 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 0.8 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.2 | 0.6 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 0.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 2.3 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 0.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.2 | 0.2 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.2 | 0.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.2 | 0.5 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.2 | 0.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.2 | 0.6 | GO:2000314 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.2 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.5 | GO:0035377 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.1 | 0.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 1.0 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 2.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.1 | 0.9 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.1 | 1.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 2.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.3 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
0.1 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 3.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.7 | GO:0015692 | lead ion transport(GO:0015692) |
0.1 | 0.7 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.1 | 0.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.1 | 0.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 1.8 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 1.2 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.1 | 0.6 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.6 | GO:0010266 | response to vitamin B1(GO:0010266) |
0.1 | 0.9 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 1.7 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 2.7 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 4.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 1.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 0.3 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.1 | 2.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.3 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 1.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.6 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.4 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 0.6 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.1 | 1.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.4 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.1 | 0.4 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.1 | 1.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 1.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 2.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 1.2 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 0.3 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.9 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.1 | 1.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.3 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 2.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 2.6 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.7 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.8 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 9.6 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 0.4 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 0.3 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 2.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.3 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 1.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 8.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 1.0 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
0.1 | 0.4 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 0.4 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.1 | 0.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.6 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 1.4 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.1 | 0.3 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.1 | 2.1 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.5 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.1 | GO:0099630 | postsynaptic neurotransmitter receptor cycle(GO:0099630) |
0.1 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 2.9 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.1 | 0.8 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.4 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 3.4 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.6 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.5 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 0.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 1.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 1.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.5 | GO:0071110 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
0.1 | 0.9 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 0.6 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 0.2 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.1 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 1.2 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 0.4 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.1 | 0.4 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
0.1 | 1.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 7.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 0.7 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.1 | 1.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.6 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.2 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.1 | 1.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.6 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 0.5 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.1 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.1 | 2.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.4 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.1 | 0.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.1 | 1.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.8 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 1.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 2.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.5 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.2 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 0.2 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 1.5 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 2.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 1.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 2.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 0.5 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 0.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.1 | 1.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.2 | GO:1903004 | flavin adenine dinucleotide metabolic process(GO:0072387) regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
0.1 | 0.6 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 1.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.3 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.6 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 2.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.6 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.1 | GO:0071284 | cellular response to lead ion(GO:0071284) |
0.1 | 0.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.3 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 1.8 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.7 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 1.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 0.3 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 0.4 | GO:0009956 | radial pattern formation(GO:0009956) |
0.1 | 0.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.1 | GO:0048241 | regulation of epinephrine secretion(GO:0014060) epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
0.1 | 0.6 | GO:0038016 | insulin receptor internalization(GO:0038016) |
0.1 | 0.6 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 0.3 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.1 | 1.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 2.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.2 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 1.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.1 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.1 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.8 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.3 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.2 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 1.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 5.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 1.5 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 1.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 3.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.2 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 1.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.2 | GO:1901355 | response to rapamycin(GO:1901355) |
0.1 | 0.6 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.1 | 3.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 1.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 0.8 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 1.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.3 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.1 | 1.0 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.3 | GO:2000686 | negative regulation of rubidium ion transport(GO:2000681) regulation of rubidium ion transmembrane transporter activity(GO:2000686) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 1.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.8 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.1 | 0.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.1 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.2 | GO:0042637 | catagen(GO:0042637) regulation of catagen(GO:0051794) |
0.1 | 0.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.5 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.5 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 1.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.1 | 0.7 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.2 | GO:1904748 | regulation of apoptotic process involved in morphogenesis(GO:1902337) regulation of apoptotic process involved in development(GO:1904748) |
0.1 | 0.8 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.1 | GO:0035801 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
0.1 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 5.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 2.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 1.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 0.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.1 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.9 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 2.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.3 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.1 | 1.3 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.2 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.1 | 0.3 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 0.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 3.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0060032 | notochord regression(GO:0060032) |
0.1 | 1.0 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.7 | GO:0006751 | glutathione catabolic process(GO:0006751) leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 0.3 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.1 | 0.1 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.4 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.1 | 0.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 0.4 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.1 | 0.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.1 | 0.3 | GO:0031445 | regulation of heterochromatin assembly(GO:0031445) positive regulation of heterochromatin assembly(GO:0031453) |
0.1 | 0.4 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.1 | 0.1 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.3 | GO:0010157 | response to chlorate(GO:0010157) |
0.1 | 0.1 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.1 | 0.8 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 0.9 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.2 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.1 | 0.6 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.1 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
0.1 | 1.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.3 | GO:0035498 | carnosine metabolic process(GO:0035498) |
0.1 | 0.6 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 1.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 2.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 2.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 2.5 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.1 | 0.3 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.1 | 0.8 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.1 | 0.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.1 | 0.4 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.9 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.1 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.1 | 1.2 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.1 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 1.5 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.3 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.1 | 0.3 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.1 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 0.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.3 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.7 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.6 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.1 | 0.2 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.1 | 0.4 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 3.3 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 1.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 1.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.2 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
0.1 | 1.2 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 0.1 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.1 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.2 | GO:0060992 | response to fungicide(GO:0060992) |
0.1 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.1 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.2 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
0.1 | 0.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 0.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 1.8 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.1 | 0.9 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.3 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
0.1 | 0.2 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 1.3 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.1 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.9 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.1 | 0.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.1 | 0.1 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 1.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.1 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.4 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.1 | 0.2 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.1 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.1 | 0.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.5 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.9 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 0.9 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.6 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.9 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.4 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.1 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 3.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.1 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.3 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 1.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.1 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 0.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 1.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 1.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 1.9 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 2.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.8 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.2 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 1.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.4 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.5 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.1 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.6 | GO:0044211 | CTP salvage(GO:0044211) |
0.1 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.2 | GO:0048687 | modulation by virus of host transcription(GO:0019056) axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) regulation of sprouting of injured axon(GO:0048686) positive regulation of sprouting of injured axon(GO:0048687) regulation of axon extension involved in regeneration(GO:0048690) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.3 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.1 | 1.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.3 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.1 | 0.8 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.1 | 0.7 | GO:1902884 | positive regulation of response to oxidative stress(GO:1902884) |
0.1 | 0.3 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
0.1 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 2.0 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.1 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.1 | 0.5 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 1.7 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.1 | 0.6 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.7 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.1 | 0.2 | GO:0055048 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.1 | 0.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.1 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.5 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 1.9 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.3 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.1 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.5 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 0.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:0006147 | guanine catabolic process(GO:0006147) |
0.1 | 0.4 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 1.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.5 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 1.7 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.1 | 0.4 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.2 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 0.3 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.1 | 1.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 2.1 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 1.5 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 | 1.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
0.1 | 0.5 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 1.8 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.3 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.9 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.2 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.1 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.1 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.1 | 0.2 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 0.7 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.3 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.1 | 0.1 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
0.1 | 0.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 1.1 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.1 | 1.1 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.1 | 0.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 0.5 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 0.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.1 | GO:0030886 | regulation of myeloid dendritic cell activation(GO:0030885) negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:0035822 | gene conversion(GO:0035822) |
0.1 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 1.0 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.1 | 0.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.2 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) |
0.1 | 0.2 | GO:1903299 | regulation of glucokinase activity(GO:0033131) negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.1 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 1.4 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.3 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 1.2 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 0.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.4 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.9 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.1 | 0.2 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.3 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.4 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.1 | 0.2 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 3.7 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.1 | 0.2 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.1 | 0.6 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.2 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.1 | 0.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.7 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.8 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.1 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.9 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 2.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.1 | 0.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.2 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.1 | 0.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.9 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.0 | 0.0 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 1.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.7 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 0.2 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 4.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 1.3 | GO:0019363 | nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.5 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.7 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 0.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.3 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.5 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.2 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.0 | 0.0 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.0 | 0.1 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.0 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.3 | GO:0010573 | vascular endothelial growth factor production(GO:0010573) |
0.0 | 0.1 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.0 | 0.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 0.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.0 | 0.5 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.0 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.4 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.0 | GO:0034699 | response to luteinizing hormone(GO:0034699) |
0.0 | 0.2 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.0 | 0.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.1 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.0 | 0.2 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.0 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.0 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.0 | 1.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0009386 | translational attenuation(GO:0009386) |
0.0 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.7 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0045872 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.1 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.0 | 0.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.6 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.0 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.0 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.0 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.3 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.6 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.7 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 0.7 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 3.4 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.2 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.0 | 0.4 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.4 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.2 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.4 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.0 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.4 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.2 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.0 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.0 | 0.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.2 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.0 | 0.1 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
0.0 | 0.3 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
0.0 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.2 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.2 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
0.0 | 0.1 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.0 | 0.1 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.0 | 0.6 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.0 | 0.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 3.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 1.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.1 | GO:0051232 | meiotic spindle elongation(GO:0051232) meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.0 | 0.3 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.0 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.0 | 0.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.0 | 0.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 0.0 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.0 | 1.1 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0003051 | brain renin-angiotensin system(GO:0002035) angiotensin-mediated drinking behavior(GO:0003051) positive regulation of gap junction assembly(GO:1903598) |
0.0 | 0.1 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.0 | 0.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.0 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.0 | 1.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 0.1 | GO:0042335 | cuticle development(GO:0042335) |
0.0 | 12.9 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 0.2 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.0 | 0.1 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 0.0 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.0 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.0 | 0.0 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.0 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.2 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.0 | 0.1 | GO:0009209 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.0 | 0.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.1 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.0 | 0.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.1 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.0 | GO:2000197 | regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.4 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.2 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.0 | 0.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.1 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.0 | 0.0 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
0.0 | 0.0 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.2 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.1 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.0 | 0.0 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.0 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.3 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.0 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.0 | 0.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.4 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.0 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0061724 | lipophagy(GO:0061724) |
0.0 | 0.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.0 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.0 | 0.5 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 2.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.6 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.0 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 1.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.0 | 0.1 | GO:0033274 | response to vitamin B2(GO:0033274) chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
0.0 | 0.8 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.0 | 0.0 | GO:0097033 | mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.0 | 1.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.0 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) |
0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.0 | 0.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.0 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.0 | 0.0 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.0 | 0.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.3 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.1 | GO:1902074 | response to salt(GO:1902074) |
0.0 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.2 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.0 | 0.0 | GO:1901890 | positive regulation of cell junction assembly(GO:1901890) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.0 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.1 | GO:0006788 | heme oxidation(GO:0006788) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 1.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0097698 | telomere maintenance via base-excision repair(GO:0097698) |
0.0 | 0.1 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.2 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.0 | 0.0 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
0.0 | 0.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.0 | 0.6 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.0 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.1 | GO:2000650 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.4 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.1 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.4 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.0 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.0 | 0.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0052330 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.0 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.0 | 2.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.0 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.1 | GO:0002357 | defense response to tumor cell(GO:0002357) |
0.0 | 0.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.0 | 0.0 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.3 | GO:0007004 | telomere maintenance via telomerase(GO:0007004) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.1 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.0 | 0.0 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.1 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.0 | 0.0 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.0 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.0 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.0 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.0 | 0.0 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.0 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.0 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) |
0.0 | 0.0 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.0 | 0.2 | GO:0097502 | mannosylation(GO:0097502) |
0.0 | 0.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.0 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.0 | 0.1 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
0.0 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.0 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.0 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.0 | 0.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.2 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 8.4 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
1.0 | 3.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.9 | 6.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.7 | 3.7 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.7 | 2.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 5.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 2.6 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.6 | 6.3 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.6 | 2.3 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.5 | 5.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 3.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.5 | 2.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 1.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.5 | 9.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.5 | 9.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 3.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.4 | 3.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 1.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
0.4 | 1.6 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.4 | 2.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 1.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 1.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 1.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.3 | 1.4 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.3 | 1.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 1.0 | GO:0032116 | SMC loading complex(GO:0032116) |
0.3 | 0.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 7.0 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 0.9 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.3 | 1.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.3 | 0.9 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.3 | 1.1 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.3 | 1.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.1 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.3 | 3.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 1.3 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.3 | 0.3 | GO:0019034 | viral replication complex(GO:0019034) |
0.3 | 4.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 1.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 0.8 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.3 | 2.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.3 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 1.2 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 1.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.2 | 0.7 | GO:0016938 | kinesin I complex(GO:0016938) |
0.2 | 2.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 1.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 1.7 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 0.6 | GO:0018444 | translation release factor complex(GO:0018444) |
0.2 | 0.6 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.2 | 3.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 0.8 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.2 | 0.6 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.2 | 11.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 2.9 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.8 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.2 | 1.1 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 3.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 2.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 0.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.2 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.2 | 0.7 | GO:0097196 | Shu complex(GO:0097196) |
0.2 | 1.6 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.2 | 1.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 4.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 0.8 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.2 | 3.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 1.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 0.5 | GO:0001534 | radial spoke(GO:0001534) |
0.2 | 0.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 2.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 0.5 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.2 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.7 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 3.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.7 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 1.3 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.1 | 0.3 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 1.0 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 2.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 2.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 2.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.5 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.1 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0060987 | lipid tube(GO:0060987) |
0.1 | 0.7 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 1.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 2.0 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 2.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 2.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 7.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.6 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 1.7 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 13.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.6 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 14.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 2.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.7 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 1.4 | GO:0030681 | multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.5 | GO:1990879 | CST complex(GO:1990879) |
0.1 | 1.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.3 | GO:1990742 | microvesicle(GO:1990742) |
0.1 | 0.9 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.8 | GO:0002177 | manchette(GO:0002177) |
0.1 | 15.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 4.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.6 | GO:0044301 | climbing fiber(GO:0044301) |
0.1 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 2.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 4.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 2.3 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.5 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 1.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.5 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 6.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 0.1 | GO:0034448 | EGO complex(GO:0034448) |
0.1 | 0.1 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 1.8 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.5 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 3.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 2.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.1 | 1.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.1 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 0.4 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
0.1 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 0.3 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 0.2 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.3 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.1 | 0.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.7 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.1 | 2.4 | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 1.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 0.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 2.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.1 | 3.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 7.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.6 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 1.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 23.6 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.3 | GO:0035517 | PR-DUB complex(GO:0035517) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 1.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 1.5 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 1.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 2.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 1.8 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 1.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.1 | 0.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 1.4 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 2.0 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 3.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 4.3 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 3.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 1.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 1.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.1 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 10.5 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 6.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.9 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 7.7 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.0 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.0 | 1.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0034455 | t-UTP complex(GO:0034455) |
0.0 | 0.1 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.0 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 1.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 1.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.0 | 27.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 2.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 7.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 1.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 1.1 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.0 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.0 | 0.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 1.6 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 14.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 0.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 3.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.1 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.1 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.0 | 1.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 4.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.6 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 1.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.7 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0032044 | DSIF complex(GO:0032044) |
0.0 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 2.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 1.0 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 18.2 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 1.9 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.0 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
0.0 | 0.0 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 3.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.0 | 1.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 3.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 1.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0033167 | ARC complex(GO:0033167) |
0.0 | 0.1 | GO:0030677 | ribonuclease P complex(GO:0030677) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 1.1 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.9 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 2.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0070449 | elongin complex(GO:0070449) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.0 | 0.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.0 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.0 | 0.0 | GO:0008623 | CHRAC(GO:0008623) |
0.0 | 11.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.0 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.0 | 44.0 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.1 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
1.3 | 6.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.2 | 3.7 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
1.0 | 2.9 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
1.0 | 2.9 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.9 | 8.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 3.1 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 2.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.7 | 6.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.7 | 2.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.7 | 7.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 1.8 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
0.6 | 3.0 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.6 | 0.6 | GO:0032427 | GBD domain binding(GO:0032427) |
0.5 | 1.6 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.5 | 2.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.5 | 2.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 4.4 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.5 | 1.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.5 | 2.4 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.5 | 7.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 1.9 | GO:0008832 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
0.5 | 0.9 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
0.4 | 1.7 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.4 | 9.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 5.5 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.4 | 1.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.4 | 5.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 2.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.4 | 1.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 2.0 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.4 | 2.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 5.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.4 | 1.1 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.4 | 1.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 1.5 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.4 | 1.8 | GO:0004803 | transposase activity(GO:0004803) |
0.4 | 2.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.4 | 1.5 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.4 | 2.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.4 | 2.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 4.7 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.4 | 2.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 1.7 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.3 | 1.4 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.3 | 1.0 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
0.3 | 2.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 1.6 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.3 | 2.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.3 | 1.0 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.3 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.3 | 2.6 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 10.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 1.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.3 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.3 | 0.3 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.3 | 2.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 0.9 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 1.5 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.3 | 1.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 4.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.3 | 0.9 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.3 | 0.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 2.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.3 | 0.9 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.3 | 0.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 1.1 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 1.7 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 0.8 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.3 | 0.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 1.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 4.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 1.7 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.3 | 0.8 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.3 | 1.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 1.1 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
0.3 | 5.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.3 | 1.3 | GO:0032181 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
0.3 | 1.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.3 | 4.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 1.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 2.9 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.3 | 1.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 0.8 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.3 | 1.0 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.3 | 2.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 3.1 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 4.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.3 | 2.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 0.3 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.3 | 0.8 | GO:0070984 | SET domain binding(GO:0070984) |
0.3 | 1.8 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 1.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.7 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.2 | 0.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 0.7 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.2 | 0.7 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.2 | 2.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 2.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.2 | 10.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.2 | 2.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.7 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.2 | 4.5 | GO:0043295 | glutathione binding(GO:0043295) |
0.2 | 0.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 0.7 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.2 | 2.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 0.7 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.2 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 0.9 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 0.7 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.2 | 0.9 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 1.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.7 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.2 | 0.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 2.2 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.2 | 0.8 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.2 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 1.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 4.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.8 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.2 | 1.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 2.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.6 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.2 | 3.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.8 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.2 | 1.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 1.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 1.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 7.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 3.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.2 | 1.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 1.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 4.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 1.0 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.2 | 2.7 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 0.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.8 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.2 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 1.7 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.2 | 1.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 3.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.9 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.2 | 0.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 1.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 3.3 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 5.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.2 | 5.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.9 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.2 | 1.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 1.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 1.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 1.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 4.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.7 | GO:1900750 | oligopeptide binding(GO:1900750) |
0.2 | 3.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 4.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 0.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.2 | 3.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 4.0 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 1.7 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.2 | 0.8 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 1.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 2.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 2.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 2.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.5 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
0.2 | 0.2 | GO:0030305 | heparanase activity(GO:0030305) |
0.2 | 0.6 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
0.2 | 3.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 0.8 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.2 | 2.1 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.2 | 0.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.2 | 0.6 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 1.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.2 | 1.6 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.2 | 0.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 1.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.5 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.2 | 1.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.5 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.2 | 0.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.5 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 0.5 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 0.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 2.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 3.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 2.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.6 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.0 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.4 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.1 | 2.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 2.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 1.1 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 0.7 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 1.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.1 | 1.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 2.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 2.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.1 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.1 | 0.5 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.1 | 1.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.7 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.7 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.1 | 2.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 2.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.4 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
0.1 | 2.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 4.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.1 | 0.7 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 0.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 2.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 1.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 4.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
0.1 | 0.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 1.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 0.4 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 5.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.5 | GO:0004079 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.1 | 1.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.4 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.1 | 1.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 1.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.4 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 0.7 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 3.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 2.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 0.4 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
0.1 | 0.4 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.1 | 1.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.3 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 3.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.2 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.1 | 1.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.0 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 0.4 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 1.9 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.6 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 1.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 1.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 8.0 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.2 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
0.1 | 1.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.4 | GO:0043273 | CTPase activity(GO:0043273) |
0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.4 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 1.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 4.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.6 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.5 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.3 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 1.1 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.1 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 3.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 3.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 1.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 1.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 0.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.4 | GO:0047708 | biotinidase activity(GO:0047708) |
0.1 | 3.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.3 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 2.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.3 | GO:0015563 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 4.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.1 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
0.1 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.3 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.1 | 1.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.4 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.1 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.7 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.6 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.1 | 2.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.3 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.1 | 1.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.7 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.1 | 3.0 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 1.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.1 | 2.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.4 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.1 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 1.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.2 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.1 | 1.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 5.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 2.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 5.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 3.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.3 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
0.1 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 3.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.4 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.7 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 10.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 3.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.6 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 1.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.4 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.3 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.8 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.1 | 1.8 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 2.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.5 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
0.1 | 0.2 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.1 | 1.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.1 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 6.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.2 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.1 | 1.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.5 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.4 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.4 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 0.1 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
0.1 | 0.1 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.1 | 0.2 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.1 | 1.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 5.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.2 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
0.1 | 1.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 2.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.7 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.1 | 0.3 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.2 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
0.1 | 0.2 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 0.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.2 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.1 | 0.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 2.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.2 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 1.8 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 1.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 1.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.6 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 19.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 2.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 1.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.3 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.1 | GO:1901474 | azole transmembrane transporter activity(GO:1901474) |
0.0 | 1.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.4 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 6.7 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 3.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 1.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.2 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.3 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.0 | 0.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 2.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.0 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 2.9 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0032093 | SAM domain binding(GO:0032093) |
0.0 | 0.5 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.0 | 2.3 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.3 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
0.0 | 0.3 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 3.0 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 1.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 2.0 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.0 | 3.5 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.0 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 1.5 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 1.5 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.1 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
0.0 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 6.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.0 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 2.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.0 | 0.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 1.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.1 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.2 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.0 | 0.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.1 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.0 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 1.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.0 | 0.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 6.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.2 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.4 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 2.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.0 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0017129 | triglyceride binding(GO:0017129) |
0.0 | 0.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.1 | GO:0043492 | ATPase activity, coupled to movement of substances(GO:0043492) |
0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.0 | 0.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.0 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.0 | GO:0070538 | oleic acid binding(GO:0070538) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.0 | 0.0 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.9 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 0.0 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.0 | 0.0 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.5 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 3.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 0.0 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 1.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 1.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 4.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.0 | 0.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.0 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.0 | 0.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.1 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.0 | 0.0 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.0 | 0.0 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.0 | 0.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 1.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 1.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 4.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 10.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 0.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 1.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 4.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 8.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 3.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 8.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 16.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.7 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 8.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 10.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 7.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 4.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 5.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 9.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 6.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 10.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 6.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 5.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 2.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 5.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 3.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 11.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 2.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 14.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 17.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 12.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 1.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 1.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 2.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 3.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 2.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 1.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.0 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 12.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.3 | 9.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.3 | 4.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 6.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 1.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 7.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 4.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 8.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 5.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 4.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 4.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 9.5 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 0.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 4.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 3.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 2.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 1.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 4.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 3.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.2 | 5.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 1.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 8.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 8.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 2.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 3.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 3.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.4 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 4.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 1.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 4.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 4.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 6.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 3.6 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 0.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 1.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 3.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 0.3 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 1.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 4.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 4.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 2.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.1 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 1.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 4.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.9 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.1 | 3.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 4.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.5 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 2.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 3.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 1.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 5.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 2.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 6.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 1.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 1.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 2.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 1.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 2.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 2.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 7.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.6 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 0.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 1.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 3.6 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.0 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 1.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |